Profile
| Metric | Value |
|---|---|
| Full Name | SAB Biotherapeutics, Inc. |
| Ticker | NASDAQ: SABS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sabbiotherapeutics.com |
| Employees | 63 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $3.77 | |
| Price, 1D Change | +0.80% | |
| $179M | ||
| - | ||
| - | ||
| 0.80 | ||
| $1M | ||
| Revenue, 1Y Change | -40.94% | |
| -$3.68 | ||
| EPS, 1Y Change | +51.81% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BCYP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.68 | ||
| EPS Estimate | N/A | -$1.00 |
| EPS Est. Change | N/A | +72.84% |
| $1.32M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $3.77 | |
| Price Target | - | $9.00 |
| Price Tgt. Change | - | +138.73% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.21 | -$7.64 | -81.51% | |
| -$3.64 | -$3.68 | -1.16% | |
| -$1.00 | N/A | +72.84% | |
| -$0.30 | N/A | +91.85% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.00 | $2.24M | -100.00% | |
| $1.32M | $1.32M | -0.06% | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $3.77 | |
| $2.38 | ||
| SMA 200 vs Price | -36.92% | |
| $3.58 | ||
| SMA 50 vs Price | -5.10% | |
| 0.80 | ||
| $0.22 | ||
| 51.40 | ||
| 33.20% | ||
| 107.61% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.32M | ||
| -$3.68 | ||
| -$3.47M | ||
| -262.42% | ||
| -$42.91M | ||
| -3,244.90% | ||
| -$34.11M | ||
| -2,579.05% | ||
| -$28.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.18 | ||
| 2.98 | ||
| 2.98 | ||
| -106.11 | ||
| - | ||
| -0.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 1,564.76 | ||
| 1.09 | ||
| -1.87 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $25.97M | ||
| $8.90M | ||
| $46.06M | ||
| $23.79M | ||
| $20.09M | ||
| $7.98M | ||
| $4.67M | ||
| $811.80K | ||
| $1.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $42.91M | ||
| $42.91M | ||
| $4.79M | ||
| $13.98M | ||
| $4.79M | ||
| $318.40K | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$34.29M | ||
| -$11.96M | ||
| -$1.17M | ||
| $337.30K | ||
| -$34.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | ||
| Chardan Capital | → | |
| Chardan Capital | → | |
| Chardan Capital | → | |
| Leerink Partners | ||
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → |
Analyst sentiment
Institutional ownership
Screeners with SABS
Data Sources & References
- SABS Official Website www.sabbiotherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1833214/000095017025046994/0000950170-25-046994-index.htm
- SABS Profile on Yahoo Finance finance.yahoo.com/quote/SABS
- SABS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sabs
FAQ
What is the ticker symbol for SAB Biotherapeutics, Inc.?
The ticker symbol for SAB Biotherapeutics, Inc. is NASDAQ:SABS
Does SAB Biotherapeutics, Inc. pay dividends?
No, SAB Biotherapeutics, Inc. does not pay dividends
What sector is SAB Biotherapeutics, Inc. in?
SAB Biotherapeutics, Inc. is in the Healthcare sector
What industry is SAB Biotherapeutics, Inc. in?
SAB Biotherapeutics, Inc. is in the Biotechnology industry
What country is SAB Biotherapeutics, Inc. based in?
SAB Biotherapeutics, Inc. is headquartered in United States
When did SAB Biotherapeutics, Inc. go public?
SAB Biotherapeutics, Inc. initial public offering (IPO) was on February 9, 2021
Is SAB Biotherapeutics, Inc. in the S&P 500?
No, SAB Biotherapeutics, Inc. is not included in the S&P 500 index
Is SAB Biotherapeutics, Inc. in the NASDAQ 100?
No, SAB Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is SAB Biotherapeutics, Inc. in the Dow Jones?
No, SAB Biotherapeutics, Inc. is not included in the Dow Jones index
When was SAB Biotherapeutics, Inc. last earnings report?
SAB Biotherapeutics, Inc.'s most recent earnings report was on March 27, 2025
When does SAB Biotherapeutics, Inc. report earnings?
The date for SAB Biotherapeutics, Inc.'s next earnings report has not been announced yet